09 Sep 2021 Newton Biocapital invests in PRISM BioLab to support development of a unique peptide mimetic technology platform to discover new drugs for intractable diseases Member news
09 Sep 2021 ViroVet and The Pirbright Institute are first to demonstrate efficacy of antivirals in ASFV infected pigs Member news
09 Sep 2021 Flamingo Therapeutics expands alliance with Ionis Pharmaceuticals to develop RNA-targeted therapies for oncology Member news
06 Sep 2021 Ardena acquires Idifarma from Suanfarma, adding spray drying technology and high potency capabilities Member news
03 Sep 2021 Novalis Biotech Acceleration invests in San Francisco-based Modality.AI - technology that ‘self-drives’ neurological and psychiatric assessments Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
